Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05815927 |
| Title | Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer (PROLoNg) |
| Acronym | PROLoNg |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | European Organisation for Research and Treatment of Cancer - EORTC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA | ESP | CHE | BEL |